National

Tourism spending may recover sooner than expected

Darpan News Desk The Canadian Press, 22 Nov, 2022 01:19 PM

VANCOUVER - Tourism spending in Canada is expected to recover sooner than previously anticipated.

Destination Canada published its latest tourism outlook today, which says it predicts tourism spending to recover to 2019 levels by 2024, up from 2025 as predicted last spring.

The government organization says that Canada's domestic travel market spending is recovering at an even faster pace and is expected to reach 92 per cent of 2019 levels in 2022 and fully recover in 2023.

It says the U.S. market is positioned to grow with spending reaching 91 per cent of 2019 levels in 2023 and expects a full economic recovery by 2024.

Destination Canada chief executive Marsha Walden says international revenue will be slower to recover due to stalls from the global recession and pandemic restrictions and should reach 2019 spending levels by 2025.

According to the report, Canada’s tourism sector could generate more than $142 billion by 2030, a 35 per cent growth over the course of the next decade.

Prev Next

MORE National ARTICLES

Copy-cat fear after Texas synagogue hostage siege

Toronto police have also increased patrols around synagogues and other Jewish community buildings, although they have said there is no known threat at this time.

Copy-cat fear after Texas synagogue hostage siege

Winter storm pummels large stretch of Ontario

Environment Canada issued snowfall, winter storm or blizzard warnings for a stretch of the province spanning from the Cornwall area to the east, the Algonquin region to the west, and the Niagara and London regions to the south.

Winter storm pummels large stretch of Ontario

China Omicron claim on Canada 'ludicrous': expert

A Chinese state-controlled news outlet first reported that the Jan. 7 infection of a Beijing resident was the result of receiving a letter or parcel from Canada that passed through Hong Kong.

China Omicron claim on Canada 'ludicrous': expert

Health Canada approves Pfizer COVID-19 drug

The agency authorized Paxlovid for adult patients with mild or moderate COVID-19 who are also at high risk of becoming more seriously ill. Health Canada did not authorize it for use on teenagers or on patients who are already hospitalized because of COVID-19

Health Canada approves Pfizer COVID-19 drug

Pfizer antiviral approved in Canada

The authorization posted to the Health Canada website Monday morning says the treatment can be used for adult patients with mild or moderate COVID-19 who are also at high risk of becoming more seriously ill.

Pfizer antiviral approved in Canada

Schools open in the West as teachers question plan

Schools in British Columbia and Alberta reopened on Monday with health and education officials stressing the need for in-person learning. Schools in Saskatchewan returned the previous week as scheduled.